Canakinumab in colchicine resistant familial Mediterranean fever and other pediatric rheumatic diseases.

Çakan M., Karadağ Ş. G., Ayaz N.

The Turkish journal of pediatrics, vol.62, pp.167-174, 2020 (SCI-Expanded) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 62
  • Publication Date: 2020
  • Doi Number: 10.24953/turkjped.2020.02.001
  • Journal Name: The Turkish journal of pediatrics
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.167-174
  • Keywords: autoinflammatory diseases, canakinumab, colchicine resistant familial Mediterranean fever, MEVALONATE KINASE, EFFICACY, RECOMMENDATIONS, MANAGEMENT, CRITERIA, CHILDREN
  • Istanbul University Affiliated: No

Abstract

Background and objectives. The aim of this observational retrospective cohort study was to demonstrate indications and response rates of the patients with pediatric rheumatic diseases that used canakinumab.